| Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961) |
|---|
| 04/27/2005 | CN1610671A Quinoline compounds with 5-HT-antagonistic properties for therapy |
| 04/27/2005 | CN1610661A Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/21/2005 | US20050085460 useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease |
| 04/21/2005 | US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 04/20/2005 | EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors |
| 04/20/2005 | CN1608054A Therapeutic quinolone compounds with 5-HT-antagonistic properties |
| 04/20/2005 | CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 04/20/2005 | CN1197578C Pharmaceutical suspension comprising nevirapine hemihydrate |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/14/2005 | WO2005021005A3 Process for the preparation of 1,4-benzodiazepine derivatives |
| 04/14/2005 | WO2004092124A3 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 04/14/2005 | US20050080265 Sleep disorders; side effect reduction |
| 04/13/2005 | EP1521744A1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
| 04/13/2005 | CN1196703C Pyrazolobenzodiazepines as CDK2 inhibitors |
| 04/12/2005 | US6878724 Polyarylcarboxamides useful as lipid lowering agents |
| 04/07/2005 | WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 04/07/2005 | US20050075329 S-tofisopam, a prodrug or a salt thereof, free of its R enantiomer, and a carrier; may also contain one or more other anticonvulsants |
| 04/07/2005 | US20050075328 Such as (2'-methoxy-[1,1'-biphenyl]-4-yl)-(5H,11H-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)methanone; for treatment of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or hemophilia |
| 04/07/2005 | US20050075327 Carbamic acid alkyl ester derivatives |
| 04/06/2005 | CN1603314A Pyrazolobenzodiazepines as CDK2 inhibitors |
| 04/06/2005 | CN1195783C Polymerization of olefins |
| 04/06/2005 | CN1195522C Benzodiazepine derivatives |
| 03/31/2005 | WO2005005394A3 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 03/31/2005 | US20050070582 For example,1-{[2-(3,5-dimethylphenoxy)-5-nitrophenyl]sulfonyl}-4-ethylpiperazine or 1-{[2-(3,5-dichlorophenoxy)-5-nitrophenyl]sulfonyl}piperazine; for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders |
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | US20050066451 Para-phenylenediamine derivatives comprising a cyclic diaza group substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers |
| 03/24/2005 | WO2004073619A3 Ccr8 antagonists |
| 03/24/2005 | US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 03/23/2005 | EP1515961A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 03/23/2005 | CN1599717A Cyclic diamine compounds having fused-ring groups |
| 03/17/2005 | WO2005023772A1 Malonamide derivatives blocking the activity of gama-secretase |
| 03/17/2005 | US20050059699 N-acylated lipophilic amino acid derivatives |
| 03/16/2005 | EP1513825A2 Anti tubercular drug: compositions and methods |
| 03/16/2005 | EP1115758B1 Polymerization of olefins |
| 03/16/2005 | CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer |
| 03/15/2005 | US6867208 Vitronectin receptor antagonists, their preparation and their use |
| 03/10/2005 | WO2005021005A2 Process for the preparation of 1,4-benzodiazepine derivatives |
| 03/10/2005 | US20050054672 Quinolinone derivatives |
| 03/10/2005 | US20050054635 Therapy , prevention of obsessive-complusive disorders; antidepressants; anxiety; schizophrenia; eating disorders; obesity; antiepileptic agents central nervous system disorders; sleep disorders |
| 03/10/2005 | US20050054633 Malonamide derivatives |
| 03/09/2005 | CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 03/08/2005 | US6864250 N-acylated lipophilic amino acid derivatives |
| 03/03/2005 | WO2004001058A3 Transcription factor modulating compounds and methods of use thereof |
| 03/02/2005 | EP1509537A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 02/24/2005 | WO2005016876A2 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 02/24/2005 | WO2004074438A3 Ccr8 antagonists |
| 02/24/2005 | US20050043397 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/24/2005 | US20050043297 Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical |
| 02/24/2005 | CA2534950A1 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 02/22/2005 | US6858605 Substituted 2,3-benzodiazepine derivatives |
| 02/22/2005 | US6858604 Cyclohepta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 02/17/2005 | US20050038081 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide |
| 02/10/2005 | WO2005012266A1 (thio) carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists |
| 02/10/2005 | WO2005012265A1 8-chloro-2,3-benzodiazepine derivatives |
| 02/10/2005 | WO2005011581A2 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/10/2005 | CA2534458A1 8-chloro-2,3-benzodiazepine derivatives |
| 02/10/2005 | CA2533893A1 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/02/2005 | EP1501841A2 Non nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 02/01/2005 | US6849630 Cyclized amino acid derivatives |
| 02/01/2005 | US6849621 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 01/27/2005 | US20050020648 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia |
| 01/27/2005 | US20050020505 Angiogenesis inhibitors; antitumor agents; anticancer agents; atherosclerosis; cardiovascular disorders; antiarthritic agents |
| 01/26/2005 | EP1379522B1 DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I |
| 01/25/2005 | CA2068224C Novel potent inducers of terminal differentiation and method of use thereof |
| 01/20/2005 | WO2005005394A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 01/20/2005 | WO2004099124A3 Novel bioisosteres of actinonin |
| 01/20/2005 | US20050014749 Piperazine derivatives and methods of use |
| 01/20/2005 | US20050014740 E.g. 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]-3,6-dihydro-2H-pyridine or piperazine or hydrochloride or oxalate; treating depression, anxiety, and obsessive compulsive disorders |
| 01/20/2005 | CA2530538A1 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 01/19/2005 | CN1568189A [[2-(amino-3, 4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain |
| 01/13/2005 | US20050009807 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
| 01/13/2005 | US20050009755 (74)(3S)-3-amino-1-(1-benzyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl)-5-methyl-2-heptanone for example; cysteine protease inhibitors; treating bone resorption diseases such as osteoporosis |
| 01/12/2005 | EP1165532B1 Antibacterial agents |
| 01/06/2005 | US20050004101 Therapy for schizophrenia, obsessive complusive disorders; antidepressants; anxiolytic agents; panic disorders; antiepileptic agents; analgesics; headaches; sleep disorders; eating disorders |
| 01/05/2005 | EP1492794A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
| 01/05/2005 | EP1492595A1 Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist |
| 01/05/2005 | CN1561336A Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 01/05/2005 | CN1183134C Tricyclic vasporessin agonists |
| 01/04/2005 | US6838558 Useful in the treatment and control of solid tumors |
| 12/30/2004 | US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 12/29/2004 | EP1491532A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetyloholine receptors |
| 12/29/2004 | EP1490344A2 Anxiolytic agents with reduced sedative and ataxic effects |
| 12/22/2004 | EP1086076B1 Sulfonamide inhibitors of aspartyl protease |
| 12/16/2004 | WO2004065390A8 Process and intermediates for the preparation of olanzapine |
| 12/16/2004 | US20040254174 Chromatography; separation of enantiomorphs |
| 12/16/2004 | US20040254167 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/16/2004 | US20040254159 Antiproliferative agents |
| 12/15/2004 | EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1226122B1 Bicyclic vasopressin agonists |
| 12/15/2004 | CN1179752C Benzodiazapine compounds containing imidazole propanamido and its preparing process and application |
| 12/09/2004 | WO2004106310A1 Novel 3-substituted-1,4-benzodiazepines |
| 12/09/2004 | CA2527195A1 Novel 3-substituted-1,4-benzodiazepines |
| 12/08/2004 | EP0920312B1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| 12/08/2004 | CN1178932C Amide derivatives |
| 12/08/2004 | CN1178923C 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists |
| 12/08/2004 | CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 12/07/2004 | US6828316 Antiallergens |
| 12/02/2004 | US20040241781 Using benzodiazepine derivatives to treat and prevent defects in programed cell death, autoimmune, inflammatory and cell proliferative diseases |
| 12/02/2004 | US20040237216 Composition for dyeing keratin fibres, comprising a cationic para-phenylenediamine derivative substituted with a diazacyclohexane or diazacycloheptane ring |